iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment.

Bioengineering (Basel) · 2025 · PMC11763340 · PMID 39851334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This approach is highly significant, as it offers the potential to create an unlimited supply of T lymphocytes with targeted antigen specificity, bypassing the need for HLA matching.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.